Envoy Medical, Inc.
COCH
$1.14
-$0.01-0.87%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 69.57% | 9.52% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 69.57% | 9.52% | |||
| Cost of Revenue | 3.54% | 43.95% | |||
| Gross Profit | 13.33% | -56.52% | |||
| SG&A Expenses | 11.47% | 12.44% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.10% | 12.86% | |||
| Operating Income | 0.72% | -12.89% | |||
| Income Before Tax | -13.85% | -8.23% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -13.85% | -8.23% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -13.85% | -8.23% | |||
| EBIT | 0.72% | -12.89% | |||
| EBITDA | 1.21% | -12.73% | |||
| EPS Basic | -11.01% | 37.81% | |||
| Normalized Basic EPS | -13.52% | 17.04% | |||
| EPS Diluted | -11.01% | 38.56% | |||
| Normalized Diluted EPS | -13.52% | 17.04% | |||
| Average Basic Shares Outstanding | 0.27% | 30.48% | |||
| Average Diluted Shares Outstanding | 0.27% | 30.48% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | 0.56% | -0.83% | |||